Back
Blueprint Medicines Stock Predictions
Top investors are buying this "unlisted" stock
This is a paid advertisement for Pacaso's Regulation A offering. Please read the offering circular and related risks at invest.pacaso.com.
Sell
31
BPMC
Blueprint Medicines
Last Price:
$84.71
Seasonality Move:
8.41%
7 Day Trial
ALL ACCESS PASS
$
7
Former Zillow execs target $1.3T market
This is a paid advertisement for Pacaso's Regulation A offering. Please read the offering circular and related risks at invest.pacaso.com.Blueprint Medicines Stock Forecast
-
Over the next 52 weeks, Blueprint Medicines has on average historically risen by 29.9% based on the past 9 years of stock performance.
-
Blueprint Medicines has risen higher in 4 of those 9 years over the subsequent 52-week period, corresponding to a historical accuracy of 44.44%
-
Is Blueprint Medicines Stock Undervalued?The current Blueprint Medicines [BPMC] share price is $84.69. The Score for BPMC is 31, which is 38% below its historic median score of 50, and infers higher risk than normal.
-
BPMC is currently trading in the 30-40% percentile range relative to its historical Stock Score levels.
Will Blueprint Medicines Stock Go Up Next Year?
-
Over the next 52 weeks, Blueprint Medicines has on average historically risen by 29.9% based on the past 9 years of stock performance.
Blueprint Medicines Stock Rating
Sell
31
Blueprint Medicines (BPMC)
is a Sell
Is Blueprint Medicines overpriced?
-
Blueprint Medicines has risen higher in 4 of those 9 years over the subsequent 52-week period, corresponding to a historical accuracy of 44.44%
Blueprint Medicines Stock Price History
Stock Information
Stock Info
Exchange:
NASDAQ
Country:
United States
Industry:
Biotechnology
Sector:
Health Care
Type:
stock
Website:
blueprintmedicines.com
52-Week Data
52-Week High:
121.90
52-Week Low:
73.04
Prediction Charts
Market Cap:
5.4B
Price in USD:
84.69
Volume:
634.4K
Beta:
0.94
Technical Analysis
SMA50:
91.11
SMA100:
94.63
SMA200:
95.51
52-Wk Change:
-4.18%
Stock Predictions
-
Is Blueprint Medicines stock public?Yes, Blueprint Medicines is a publicly traded company.
-
What is the Blueprint Medicines stock quote today?The Blueprint Medicines stock price is 84.69 USD today.
-
How to buy Blueprint Medicines stock online?You can buy Blueprint Medicines shares by opening an account at a top tier brokerage firm, such as TD Ameritrade or tastyworks.
14-Day Historical Data
| Date | Opening | Closing | Minimum | Maximum |
|---|---|---|---|---|
| Mar-31 | 86.82 | 88.51 | 88.74 | 85.35 |
| Apr-1 | 88.51 | 85.94 | 88.67 | 84.55 |
| Apr-2 | 85.18 | 90.01 | 90.39 | 85.10 |
| Apr-3 | 86.36 | 87.11 | 89.14 | 86.21 |
| Apr-4 | 85.51 | 81.68 | 86.00 | 80.08 |
| Apr-7 | 79.00 | 80.20 | 83.91 | 76.50 |
| Apr-8 | 82.09 | 79.22 | 84.66 | 77.36 |
| Apr-9 | 77.49 | 82.05 | 83.54 | 73.04 |
| Apr-10 | 78.48 | 80.27 | 81.86 | 76.84 |
| Apr-11 | 78.50 | 80.84 | 81.28 | 77.63 |
| Apr-14 | 82.38 | 82.53 | 83.50 | 79.91 |
| Apr-15 | 81.93 | 81.45 | 83.45 | 79.91 |
| Apr-16 | 81.05 | 82.11 | 82.18 | 78.66 |
| Apr-17 | 82.16 | 84.69 | 84.97 | 81.19 |
Blueprint Medicines Earnings
Blueprint Medicines Earnings Report: Per Share Blueprint Medicines Earnings Q1 Q2 Q3 and Q4 last year and next year.
Blueprint Medicines Forecast Revenue Growth
Blueprint Medicines Stock Analysis: Historical quarterly revenues per share for Blueprint Medicines and historical quarterly revenue growth:
-
Analysts estimate an earnings decrease this quarter of $0.63 per share, an increase next quarter of $0.06 per share, a decrease this year of $0.28 per share, and an increase next year of $2.63 per share.
* Blueprint Medicines stock forecasts short-term for next days and weeks may differ from long term prediction for next month and year based on timeline differences.